Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nutriband Inc. - Common Stock (NQ:NTRB)

8.350 +0.510 (+6.51%)
Streaming Delayed Price Updated: 3:32 PM EDT, Oct 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Nutriband Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) to Present at Noble Capital Markets Emerging Growth Virtual Equity Conference
Via Investor Brand Network
Nutriband Files Provisional Patent Application for Enhanced Transdermal Abuse Deterrent Technology
From Nutriband Inc.
Via GlobeNewswire
Nutriband To Present at the Noble Capital Markets’ Emerging Growth Virtual Equity Conference
From Nutriband Inc.
Via GlobeNewswire
InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) to Present at MicroCap Rodeo Conference
Via Investor Brand Network
11 Company Presentations Today at The MicroCap Rodeo Conference
Via ACCESS Newswire
Nutriband Inc. to Present at the MicroCap Rodeo Conference
Thursday, September 25, 2025 in New York City 
From Nutriband Inc.
Via GlobeNewswire
MissionIRNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Eyes Clear Development Pathway for AVERSA(TM) Technology
Via Investor Brand Network
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Reports 51% Revenue Growth, Strong Cash Position to Advance AVERSA Fentanyl
Via Investor Brand Network
Nutriband Inc. (NASDAQ: NTRB): When Market Confidence Validates Scientific Innovation
Via Investor Brand Network
Nutriband Inc. Quarterly Report Highlights Record Revenue for Q2, 2025 up 50.87% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl
From Nutriband Inc.
Via GlobeNewswire
InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Scales Manufacturing, Eyes Global Commercialization of AVERSA(TM)
Via Investor Brand Network
Topics Intellectual Property
Nutriband Inc. (NASDAQ: NTRB) CEO Showcases AVERSA(TM) Abuse Deterrent Transdermal Technology at Emerging Growth Conference
Via Investor Brand Network
Topics Initial Public Offering
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Secures $5.3 Million from Warrant Exercises to Advance AVERSA Fentanyl NDA
Via Investor Brand Network
Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $5,306,000
From Nutriband Inc.
Via GlobeNewswire
Nutriband Inc. (NASDAQ: NTRB): When Regulatory Momentum Meets Leadership Continuity
Via Investor Brand Network
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) to Present at Emerging Growth Conference on August 20
Via Investor Brand Network
Nutriband Inc. to Present on the Emerging Growth Conference on August 20, 2025
Nutriband Inc. invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation on the Emerging Growth Conference 
From Nutriband Inc.
Via GlobeNewswire
InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) CEO Steps Aside Temporarily to Run for Irish Presidency
Via Investor Brand Network
Topics Intellectual Property
Nutriband CEO Gareth Sheridan Seeks Nomination in Upcoming Irish Presidential Election
From Nutriband Inc.
Via GlobeNewswire
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Secures FDA Type C Meeting for AVERSA(TM) Fentanyl Abuse-Deterrent Patch
Via Investor Brand Network
Topics Intellectual Property
FDA Grants Nutriband Meeting Request for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch
From Nutriband Inc.
Via GlobeNewswire
Nutriband Inc. (NASDAQ: NTRB) Navigates Drug-Delivery Challenges with Innovation in Abuse-Deterrent Tech
Via Investor Brand Network
Nutriband Inc. (NASDAQ: NTRB) Aligns Shareholder Value with FDA Milestone
Via Investor Brand Network
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB): Innovation Meets Science Through Scalable Platform
Via Investor Brand Network
Topics Intellectual Property
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Sets Key Dates for 25% Preferred Stock Dividend
Via Investor Brand Network
Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA Approval
From Nutriband Inc.
Via GlobeNewswire
InvestorNewsBreaks – Rare Biotech Story: Nutriband Inc. (NASDAQ: NTRB) Founder Shares Vision in Smart Money Circle Podcast
Via Investor Brand Network
Nutriband Inc. (NASDAQ: NTRB) Added to Four Key Indexes, Rethinking Opioid Safety in a Time of Crisis
Via Investor Brand Network
Topics Intellectual Property
InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Declares 25% Preferred Stock Dividend Linked to AVERSA Fentanyl Approval
Via Investor Brand Network
Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval
From Nutriband Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.